Mesenchymal Stem Cells (MSCs)

Mesenchymal stem cells (MSCs) are a well-characterized population of adult stem cells that can differentiate into a variety of cell types (chondrocytes, osteoblasts, adipocytes, myocytes, and more).

Americord Registry Launches Pricing Calculator for Cord Blood Banking Services

October 13, 2016 By Cade Hildreth, Founder & President Leave a Comment

NEW YORK, New York — Americord, the fastest growing cord blood bank in the country, and a leader in the advancement of umbilical cord blood, cord tissue, and placenta tissue banking, announces the launch of its Cord Blood Banking Pricing Calculator. [Read more…]

Pall Corporation and RoosterBio to Co-Market Mesenchymal Stem/Stromal Cells and Bioreactors

October 5, 2016 By Cade Hildreth, Founder & President Leave a Comment

The agreement will encompass a co-development and marketing partnership.

RoosterBio, “Radically Changing the Use of Stem Cells”

OCTOBER 05, 2016 –Pall Corporation, a global leader in bioprocess equipment and disposables, announced the signing of a commercial collaboration agreement with RoosterBio Inc, an innovative adult stem cell technology company. The agreement will encompass a co-development and marketing partnership, delivering complete solutions for industrial-scale bioreactor expansion of human Mesenchymal Stem/Stromal Cells (hMSCs). [Read more…]

CDI Launches Opsis, Provia Expands Perinatal Storage, CCBC Gets Biologics License

September 28, 2016 By Cade Hildreth, Founder & President Leave a Comment

We have released coverage of this week’s stem cell industry activity that I am excited to share with you. It was a major week for stem cells, with CDI launching Opsis Therapeutics, Provia Laboratories expanding its stem cell product portfolio, CCBC getting a FDA Biologics License for CLEVECORD™, STEMCELL Technologies exploring genomic instability in an upcoming webinar, and iPSCs turning 10. [Read more…]